The European Bank for Reconstruction and Development (EBRD) has provided JSC Farmak (Kyiv) with a loan of EUR 20 million to replenish working capital, according to a press release from the EBRD.
"The EBRD is lending EUR 20 million to a leading Ukrainian pharmaceuticals manufacturer, JSC Farmak, under its EUR 2 billion Resilience and Livelihoods Framework supporting countries affected by the war in Ukraine," the report says.
The program provides for the sustainability and preservation of livelihoods and support for countries affected by the war in Ukraine.
According to the EBRD, the total amount of the Program is EUR 2 billion.
The EBRD reports that this loan has a 5.5% first loss guarantee under the EBRD's Shareholder Special Fund Risk Sharing Programme. Thus, the total donor guarantee will cover 50% of the loan amount.
Advertising
Advertising
MORE ABOUT
EBRD provides Credit Agricole Bank EUR 150 mln guarantee for business lending
09:57, 03.12.2025
EBRD to provide Ukrhydroenergo EUR 75 mln, expects additional EUR 20 mln in investment grants
20:34, 02.12.2025
EBRD provides guarantee for Ukrsibbank loan to develop EVA logistics hubs
13:36, 26.11.2025
Ukrainian pharma manufacturers lose 3-5% of revenues due to state regulation – expert
11:10, 18.11.2025
IFC and EBRD co-invest $25 mln in Dragon Capital's Rebuild Ukraine Fund
11:55, 14.11.2025
LATEST
Ukrainian business calls for revisions to bill on control over production, circulation of tobacco raw materials
20:28, 16.12.2025
Demand for passenger cars from China in Ukraine nearly quintuples in Nov – Ukrautoprom
19:27, 16.12.2025
Possibility found to free up at least 800 MW of electrical capacity – Ukrainian PM
17:52, 16.12.2025
Ukrainian cheeses continue to lose share of domestic market – analysts
14:45, 16.12.2025
Ukraine’s Justice Ministry seeks recovery of 25% stake in Kriukov Car Building Works from Russian citizen